Return to Listing

1 result(s) for MSB0010718C

PI Name Protocol # Title
Matthew Taylor IRB00010177 A Phase I, Open-Label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of avelumab (MSB0010718C) in Subjects with Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080